U.S. Office REITs Stock News

Navitas Semiconductor (NVTS) is back in the spotlight after CEO Chris Allexandre’s scheduled presentation at the 28th Annual Needham Growth Conference on January 14, 2026, which is drawing fresh attention to its AI data center ambitions. See our latest analysis for Navitas Semiconductor. The recent 9.1% 1 day share price return and 39.7% 30 day share price return suggest momentum is rebuilding after a 19.8% 90 day decline. The 206.5% 1 year total shareholder return points to a much stronger...

IBM launched IBM Enterprise Advantage, a new offering focused on enterprise AI adoption and governance. The company announced a collaboration with e& to deploy one of the region's first enterprise-grade agentic AI governance solutions. IBM also worked on GRAMMY IQ, applying its AI capabilities to fan engagement in entertainment. International Business Machines (NYSE:IBM) is leaning further into enterprise AI with products and partnerships that aim to embed AI into core business and...

Adobe (ADBE) is back in focus after Inspired Thinking Group said it will plug Adobe Firefly’s generative AI into its Storyteq content marketing platform, pairing Firefly with ITG’s Halo Intelligence for AI driven content workflows. See our latest analysis for Adobe. Despite Adobe’s push to embed Firefly into real world workflows like ITG’s Storyteq platform, sentiment has stayed cautious, with a 30 day share price return of 18.4% and a 1 year total shareholder return decline of 33.5%,...

Accenture (NYSE:ACN) subsidiary BOSLAN has been selected by ScottishPower Renewables to supervise key aspects of the East Anglia TWO offshore wind farm project. Accenture announced the integration of Faculty's AI team into the firm, with Faculty CEO Marc Warner set to become Accenture's chief technology officer. For you as an investor, these two updates sit at the intersection of digital services and energy transition work, which are central to Accenture's consulting and technology...

UnitedHealth Group (UNH) is back in the spotlight after a U.S. Senate committee alleged aggressive Medicare Advantage risk adjustment practices, while President Donald Trump’s healthcare reform proposal targets insurance brokers and other middlemen. See our latest analysis for UnitedHealth Group. At a share price of $338.43, UnitedHealth Group has seen a 1-day share price return of 2.24% and a 30-day share price return of 3.36%. However, its 1-year total shareholder return of 33.95% decline...

Strategy Inc. (NasdaqGS:MSTR) acquired 22,305 Bitcoin for US$2.13b, its largest purchase in over a year. The company now holds more than 700,000 BTC, reinforcing its focus on a Bitcoin centric treasury model. The purchase was funded through equity and preferred stock issuance, adding to existing shareholder dilution. Large asset managers, including Vanguard and BlackRock, have increased exposure to Strategy equity and preferred securities. State pension funds such as LASERS reported new...

In recent months, Carrier Global has attracted increased attention as insiders, including Chairman and CEO David L. Gitlin, bought shares while major institutions such as PineStone Asset Management and UBS Asset Management expanded their holdings. Analysts have also updated their views and ratings, and the company previously announced plans to report its fourth quarter 2025 results on February 5, 2026. This combination of insider confidence, growing institutional ownership and active analyst...

Apple (NasdaqGS:AAPL) faces a potential multi billion dollar fine in India as regulators pursue an antitrust case that could apply penalties to its global revenue base. The company is challenging the penalty framework in Indian courts while continuing to operate its App Store and ecosystem in the country. Apple has agreed a partnership with Google to use Gemini models to power future versions of Siri and other AI features across its products. The Gemini collaboration points to a shift in...

Wondering if Visa's share price still makes sense for long term holders at around US$325.82, or if the value case has cooled off? This article walks through what the current valuation signals are really telling you. The stock has been fairly steady over the last year with a 1.4% return, but the recent 6.7% decline over 30 days and 6.0% year to date fall may be changing how the market is thinking about upside and risk. Recent news flow around payment volumes, partnerships and broader...

Eli Lilly (NYSE:LLY) received FDA Breakthrough Therapy designation for sofetabart mipitecan, an ovarian cancer drug candidate. The designation covers treatment of adults with platinum resistant ovarian cancer. The FDA decision is based on early clinical data and is intended to expedite development and review. For you as an investor, this update highlights how Eli Lilly is building out its oncology pipeline alongside its well known obesity franchise. Sofetabart mipitecan targets a hard to...

Conference spotlight and contract win reshape the Rocket Lab story Morgan Stanley’s rating upgrade on Rocket Lab (RKLB), along with the roughly $816 million U.S. Space Development Agency satellite contract, has turned the stock into a focal point for investors watching the space sector. At the same time, Rocket Lab is preparing to present at the BofA Securities 2026 Defense Outlook and Commercial Aerospace Forum in New York. This gives CFO Adam C. Spice a high-profile stage to discuss launch...

BofA Securities’ recent downgrade of Arm Holdings (ARM), tied to softer smartphone demand, higher memory costs, and slower royalty revenue, has sharpened attention on the stock just as the company ramps up its new Physical AI division. See our latest analysis for Arm Holdings. At a share price of US$107.17, Arm’s recent 30 day share price return of 6.02% decline and 90 day share price return of 35.33% decline, alongside a 1 year total shareholder return of 30.95% decline, point to fading...

Ascendis Pharma (NasdaqGS:ASND) reported positive topline Week 52 results from its COACH Phase 2 trial in children with achondroplasia. The combination therapy showed durable growth, improved body proportionality, and a favorable safety profile over the 52 week period. The data support the company’s achondroplasia program as a potential backbone treatment approach for pediatric patients. Ascendis Pharma, a biopharmaceutical company focused on endocrinology related rare diseases, is...

If you are wondering whether DocuSign's current share price reflects its true value, you are not alone; many investors are asking what a fair price for this stock looks like right now. The stock last closed at US$55.82, with returns of a 13.5% decline over 7 days, a 20.2% decline over 30 days, a 13.9% decline year to date, a 38.9% decline over 1 year and a 76.3% decline over 5 years, which has naturally raised questions about risk and future return potential. Recent coverage has focused on...

In recent weeks, Huntington Ingalls Industries’ Mission Technologies division secured places on the Advanced Technology Support Program V contract and the Missile Defense Agency’s SHIELD IDIQ, opening access to multi-year engineering and advanced defense technology work across hardware, software, and integrated mission systems. Alongside expanded unmanned systems operations in the U.K. and successful autonomous undersea launch-and-recovery trials, these awards highlight HII’s growing role...

Mercury Systems (MRCY) has just secured more than US$60 million in contracts tied to U.S. space and weapons programs, including a development extension through 2031 and a fresh national security space subsystem award. See our latest analysis for Mercury Systems. These contract wins land after a sharp 39.4% 1 month share price return and a 27.7% year to date share price return, with 1 year total shareholder return of 122.8% indicating strong momentum despite a recent 5.8% 1 day pullback. If...

Why Energy Transfer is on investors’ radar right now Energy Transfer (ET) is drawing attention as investors weigh its recent share performance, including a return of about 6% over the past month and roughly 3% in the past 3 months. See our latest analysis for Energy Transfer. At a share price of $17.44, Energy Transfer has seen a 6.41% 1 month share price return and a 5.12% year to date share price return, while its 1 year total shareholder return of a 10.20% decline contrasts with a very...

SLB (NYSE:SLB) has partnered with Libya’s National Oil Corporation and Omar Al Mukhtar University. The collaboration focuses on industry aligned education, scientific research, and sustainability in Libya’s oil and gas sector. Key priorities include workforce development, zero routine gas flaring, and carbon capture initiatives. SLB, a global oilfield services and technology provider, is tying its expertise more closely to Libya’s upstream sector through this education and research focused...

Peoples Bancorp (PEBO) has put up a solid set of headline numbers for FY 2025 Q3, with total revenue of US$107.9 million, basic EPS of US$0.83 and net income of US$29.2 million, while its net profit margin over the last twelve months sits at 18.2% compared with 24.6% a year earlier. Over recent quarters the company has seen revenue move from US$106.97 million in FY 2024 Q3 to US$97.82 million in FY 2025 Q2 and then to US$107.9 million in FY 2025 Q3, alongside quarterly EPS prints of US$0.90,...

Mercantile Bank (MBWM) just posted its FY 2025 third quarter numbers with total revenue of US$62.2 million and basic EPS of US$1.46, alongside net income, excluding extra items, of US$23.8 million, giving investors a clean read on core profitability. The bank has seen revenue move from US$56.9 million in Q3 2024 to US$62.2 million in Q3 2025, while quarterly EPS has shifted from about US$1.22 to US$1.46 over the same period. Trailing twelve month EPS is roughly US$5.28, and investors are...

Meta Platforms (META) is back in focus after a sharp ramp in AI and data center spending, with capital expenditure guidance above US$70b and a clear pivot away from virtual reality projects. See our latest analysis for Meta Platforms. The recent AI spending ramp and Reality Labs cuts sit against a pullback in the shares, with a 30 day share price return of 8.30% and a 90 day share price return of 17.63%, while the 3 year total shareholder return of about 3.3x still reflects how much value...

What SoFi’s recent performance numbers tell you With no single headline event driving SoFi Technologies (SOFI) today, investors are instead working with a set of recent return figures and fundamentals to gauge how the stock currently looks. Over the past week, the share price has recorded a 6.1% decline, with a similar 6.4% decline over the past month and 6.2% decline over the past 3 months. Year to date, the stock is down 7.2%, although the 1 year total return stands at 42.4% and the 3 year...

Rigetti Computing (RGTI) is back on investors’ radar after its recent share performance, with the stock closing at US$24.99 as traders weigh its quantum computing focus against ongoing losses and early stage revenues. See our latest analysis for Rigetti Computing. That US$24.99 share price comes after a mixed stretch, with a 5.18% 30 day share price return and a 30.70% decline over 90 days. At the same time, a very strong 3 year total shareholder return suggests long term investors have...

In January 2026, Castle Biosciences reported that 2025 total revenue is expected to exceed US$340 million, above its prior US$327–US$335 million range, alongside strong year-on-year growth in test volumes for its core DecisionDx-Melanoma and TissueCypher Barrett’s Esophagus assays. The sharp increase in core test reports, particularly for TissueCypher, suggests that Castle’s efforts to broaden clinical adoption and utilization are gaining traction across its key diagnostic franchises. Now...